Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery

Viruses. 2022 Jul 16;14(7):1557. doi: 10.3390/v14071557.

Abstract

In this review, we explore recombination in two very different virus families that have become major threats to human health. The Herpesviridae are a large family of pathogenic double-stranded DNA viruses involved in a range of diseases affecting both people and animals. Coronaviridae are positive-strand RNA viruses (CoVs) that have also become major threats to global health and economic stability, especially in the last two decades. Despite many differences, such as the make-up of their genetic material (DNA vs. RNA) and overall mechanisms of genome replication, both human herpes viruses (HHVs) and CoVs have evolved to rely heavily on recombination for viral genome replication, adaptation to new hosts and evasion of host immune regulation. In this review, we will focus on the roles of three viral exonucleases: two HHV exonucleases (alkaline nuclease and PolExo) and one CoV exonuclease (ExoN). We will review the roles of these three nucleases in their respective life cycles and discuss the state of drug discovery efforts against these targets.

Keywords: ExoN; alkaline nuclease; antiviral; coronavirus; exonucleases; herpesvirus; nucleases; proofreading; recombination.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Coronavirus Infections*
  • Coronavirus* / genetics
  • Drug Discovery
  • Exonucleases
  • Humans
  • Mutation
  • Recombination, Genetic
  • Simplexvirus
  • Virus Replication

Substances

  • Antiviral Agents
  • Exonucleases